Sandra Villar

Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life, and Natriuretic Peptides after initiation of Dapagliflozin in Heart Failure with Reduced Ejection Fraction.

A. Bayés‐Genís, E. Núñez, J. Núñez, 2023, Journal of Cardiac Failure.

An update on utilising brain natriuretic peptide for risk stratification, monitoring and guiding therapy in heart failure

A. Bayés‐Genís, J. Sanchis, G. Miñana, 2023, Expert review of molecular diagnostics.

Early glomerular filtration rates changes and risk of mortality in acute heart failure. The modifying role of admission renal function and decongestion.

A. Bayés‐Genís, V. Bodí, J. Sanchis, 2023, European journal of internal medicine.

Peritoneal and Urinary Sodium Removal in Refractory Congestive Heart Failure Patients Included in an Ambulatory Peritoneal Dialysis Program: Valuable for Monitoring the Course of the Disease

E. Núñez, J. Górriz, G. Miñana, 2023, Cardiorenal medicine.

Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA).

M. Anguita Sánchez, M. T. Pérez-Martínez, Sandra Villar, 2024, European journal of heart failure.